Fidelity Advisor Biotechnology Fund - Class I (FBTIX)
| Fund Assets | 1.87B |
| Expense Ratio | 0.74% |
| Min. Investment | $0.00 |
| Turnover | 51.00% |
| Dividend (ttm) | 0.57 |
| Dividend Yield | 1.38% |
| Dividend Growth | -66.33% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 26, 2025 |
| Previous Close | 41.61 |
| YTD Return | 0.63% |
| 1-Year Return | 42.51% |
| 5-Year Return | 38.44% |
| 52-Week Low | 23.91 |
| 52-Week High | 43.26 |
| Beta (5Y) | 0.54 |
| Holdings | 88 |
| Inception Date | Dec 27, 2000 |
About FBTIX
Fidelity Advisor Biotechnology I is an actively managed mutual fund focused on the biotechnology sector. The fund primarily seeks capital appreciation by investing at least 80% of its assets in companies engaged in the research, development, manufacture, and distribution of biotechnological products, services, and processes. These holdings include firms that benefit from significant scientific and technological advances within the biotechnology industry. The portfolio is concentrated in both domestic and international issuers, relying on rigorous fundamental analysis of each issuer’s financial health, industry standing, and broader economic conditions. With a substantial allocation to industry leaders such as AbbVie, Amgen, and Regeneron Pharmaceuticals, the fund is non-diversified, emphasizing select opportunities in biotech innovation. Managed by a specialized team leveraging deep scientific and clinical expertise, Fidelity Advisor Biotechnology I plays a specialized role in the market by offering investors targeted exposure to one of the most dynamic and research-driven segments of healthcare. The fund is frequently used by institutions and investors for tactical or strategic allocation to capture long-term growth trends driven by advancements in medical technology and drug development.
Performance
FBTIX had a total return of 42.51% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.81%.
Top 10 Holdings
53.99% of assets| Name | Symbol | Weight |
|---|---|---|
| AbbVie Inc. | ABBV | 17.22% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 6.31% |
| Gilead Sciences, Inc. | GILD | 5.75% |
| argenx SE | ARGX | 4.55% |
| Ascendis Pharma A/S | ASND | 4.29% |
| Cogent Biosciences, Inc. | COGT | 3.98% |
| Insmed Incorporated | INSM | 3.40% |
| Viridian Therapeutics, Inc. | VRDN | 3.01% |
| Biogen Inc. | BIIB | 2.81% |
| Amgen Inc. | AMGN | 2.68% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 26, 2025 | $0.572 | Dec 29, 2025 |
| Dec 26, 2024 | $1.699 | Dec 27, 2024 |
| Dec 21, 2023 | $0.407 | Dec 22, 2023 |
| Dec 17, 2021 | $5.411 | Dec 20, 2021 |
| Jul 9, 2021 | $0.135 | Jul 12, 2021 |
| Dec 18, 2020 | $2.917 | Dec 21, 2020 |